Hercules Capital HTGC Stock
Hercules Capital Price Chart
Hercules Capital HTGC Financial and Trading Overview
| Hercules Capital stock price | 15.81 USD |
| Previous Close | 16.05 USD |
| Open | 16 USD |
| Bid | 15.75 USD x 30000 |
| Ask | 15.89 USD x 30000 |
| Day's Range | 15.79 - 16.01 USD |
| 52 Week Range | 13.7 - 19.13 USD |
| Volume | 1.45M USD |
| Avg. Volume | 1.39M USD |
| Market Cap | 3B USD |
| Beta (5Y Monthly) | 0.746 |
| PE Ratio (TTM) | 8.475936 |
| EPS (TTM) | 1.87 USD |
| Forward Dividend & Yield | 1.88 (11.70%) |
| Ex-Dividend Date | November 10, 2026 |
| 1y Target Est | 19.5 USD |
HTGC Valuation Measures
| Enterprise Value | 5.52B USD |
| Trailing P/E | 8.475936 |
| Forward P/E | 8.127163 |
| PEG Ratio (5 yr expected) | 0.52 |
| Price/Sales (ttm) | 5.287531 |
| Price/Book (mrq) | 1.275962 |
| Enterprise Value/Revenue | 9.714 |
| Enterprise Value/EBITDA | 11.522 |
Trading Information
Hercules Capital Stock Price History
| Beta (5Y Monthly) | 0.746 |
| 52-Week Change | -9.11% |
| S&P500 52-Week Change | 13.08% |
| 52 Week High | 19.13 USD |
| 52 Week Low | 13.7 USD |
| 50-Day Moving Average | 16.82 USD |
| 200-Day Moving Average | 16.06 USD |
HTGC Share Statistics
| Avg. Volume (3 month) | 1.39M USD |
| Avg. Daily Volume (10-Days) | 1.86M USD |
| Shares Outstanding | 189.55M |
| Float | 174.02M |
| Short Ratio | 9.06 |
| % Held by Insiders | 1.92% |
| % Held by Institutions | 34.82% |
| Shares Short | 10.31M |
| Short % of Float | 5.54% |
| Short % of Shares Outstanding | 5.43% |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.6 |
| Trailing Annual Dividend Yield | 9.96% |
| 5 Year Average Dividend Yield | 1017.00% |
| Payout Ratio | 1.0053 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 62.84% |
| Operating Margin (ttm) | 84.25% |
| Gross Margin | 100.00% |
| EBITDA Margin | 84.31% |
Management Effectiveness
| Return on Assets (ttm) | 6.39% |
| Return on Equity (ttm) | 15.81% |
Income Statement
| Revenue (ttm) | 568.2M USD |
| Revenue Per Share (ttm) | 3.08 USD |
| Quarterly Revenue Growth (yoy) | 1.50% |
| Gross Profit (ttm) | 568.2M USD |
| EBITDA | 479.06M USD |
| Net Income Avi to Common (ttm) | 354.11M USD |
| Diluted EPS (ttm) | 1.87 |
| Quarterly Earnings Growth (yoy) | -21.80% |
Balance Sheet
| Total Cash (mrq) | 48.33M USD |
| Total Cash Per Share (mrq) | 0.26 USD |
| Total Debt (mrq) | 2.56B USD |
| Total Debt/Equity (mrq) | 110.34 USD |
| Current Ratio (mrq) | 1.409 |
| Book Value Per Share (mrq) | 12.422 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -153963008 USD |
| Levered Free Cash Flow (ttm) | 276.41M USD |
Profile of Hercules Capital
| Country | United States |
| State | CA |
| City | San Mateo |
| Address | 1 North B Street |
| ZIP | 94401 |
| Phone | (650) 289-3060 |
| Website | https://www.htgc.com |
| Industry | Asset Management |
| Sector(s) | Financial Services |
| Full Time Employees | 100 |
Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels, and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, drug platform, development, and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. Within sustainable and renewables, it invests in Vehicle Technology, Energy Generation and Storage, Ag Technology, Advanced Materials, and Industry 4.0. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest, particularly in the areas of software, biotech, and information services. The firm prefers to invest between $5 million and $500 million in equity per transactions. It invests in debt between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in San Mateo, California with additional offices in North America and Europe.
Q&A For Hercules Capital Stock
What is a current HTGC stock price?
Hercules Capital HTGC stock price today per share is 15.81 USD.
How to purchase Hercules Capital stock?
You can buy HTGC shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hercules Capital?
The stock symbol or ticker of Hercules Capital is HTGC.
Which industry does the Hercules Capital company belong to?
The Hercules Capital industry is Asset Management.
How many shares does Hercules Capital have in circulation?
The max supply of Hercules Capital shares is 189.55M.
What is Hercules Capital Price to Earnings Ratio (PE Ratio)?
Hercules Capital PE Ratio is 8.45187200 now.
What was Hercules Capital earnings per share over the trailing 12 months (TTM)?
Hercules Capital EPS is 1.87 USD over the trailing 12 months.
Which sector does the Hercules Capital company belong to?
The Hercules Capital sector is Financial Services.
Hercules Capital HTGC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
NYSE Composite Index
NYA
US
|
24428.54 USD — |
-0.16
|
— — | 24351.43 USD — | 24596.1 USD — | — - | — — |


